Modern Africa Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.

Press releases published on August 5, 2026

Grand Lakes Veículos Strengthens Its ESG Agenda and Expands Social Impact in Angola
What is a DBA? Complete guide to the Doctor of Business Administration
Trekor Announces $125 Million of Adjusted EBITDA in Second Quarter
Equinox Gold Delivers Strong Second Quarter Results; Increases 2026 Production Guidance Following Successful Completion of the Orla Mining Merger; Quarterly Dividend Increased by 50%
Aura Declares Dividend of US$0.72 Per Share and US$0.24 Per BDR Based on Q2 2026 Results, Resulting in a Dividend Yield of 4.3% in the LTM
Aura Announces Q2 2026 and H1 2026 Financial and Operational Results, a Record First Half Result
Ero Copper Reports Second Quarter 2026 Operating and Financial Results
Equinox Gold Increases Cash Dividend by 50%; Declares Quarterly Cash Dividend of US$0.0225 per Common Share
Snowline Gold Announces C$150 Million Bought Deal Financing
BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates
Central Bank Language Can Move Currency Markets Even When Rates Stay Unchanged
OR Royalties Declares Third Quarter 2026 Dividend
Redevances OR Déclare un Dividende pour le Troisième Trimestre de 2026
OR Royalties Reports 62% Year-Over-Year Increase in Revenues and Cash Flows from Operations in Q2 2026 and Continued Share Repurchases Under the Normal Course Issuer Bid
Redevances OR annonce une hausse de 62 %, d’une année sur l’autre, des produits et des flux de trésorerie générés par les activités d'exploitation au deuxième trimestre de 2026, et la poursuite des rachats d'actions dans le cadre de l’offre publique de…
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026
Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Revolution Medicines Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Modern Africa Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.